Machina Capital S.A.S. Boosts Stock Position in Danaher Corporation $DHR

Machina Capital S.A.S. raised its stake in shares of Danaher Corporation (NYSE:DHR) by 56.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,892 shares of the conglomerate’s stock after acquiring an additional 8,215 shares during the period. Danaher makes up 0.9% of Machina Capital S.A.S.’s investment portfolio, making the stock its 17th biggest holding. Machina Capital S.A.S.’s holdings in Danaher were worth $4,522,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nuveen LLC acquired a new position in Danaher during the 1st quarter worth approximately $833,941,000. Invesco Ltd. increased its position in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the period. Baird Financial Group Inc. increased its position in Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after purchasing an additional 1,072,617 shares during the period. Generation Investment Management LLP increased its position in Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock worth $651,515,000 after purchasing an additional 791,662 shares during the period. Finally, Parnassus Investments LLC increased its position in Danaher by 23.3% during the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock worth $784,745,000 after purchasing an additional 722,636 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DHR. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Royal Bank Of Canada set a $241.00 target price on Danaher in a research report on Tuesday, September 2nd. JPMorgan Chase & Co. upped their price target on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Finally, Barclays upped their price target on Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Stock Performance

DHR opened at $215.63 on Monday. The stock’s 50 day simple moving average is $203.41 and its 200 day simple moving average is $199.60. The stock has a market cap of $152.31 billion, a P/E ratio of 44.46, a P/E/G ratio of 3.28 and a beta of 0.77. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio is 26.39%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.